Malignant features related PRDX1 associated with osimertinib sensitivity of EGFR-mutant lung adenocarcinoma
International Journal of Medical Sciences · 31.03.2025 · 22 (9) · 2040-2058
DOI: 10.7150/ijms.107255 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, erschienen am 31.03.2025. Verfasst von Wenying Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China. Hauptthemen laut MEDLINE: Peroxiredoxins, Adenocarcinoma of Lung, Acrylamides, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
- Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha 410000, Hunan, China.
- Departments of Ultrasound Imaging, Xiangya Hospital, Central South University, Changsha 410008, Hunan, China.
- Department of Blood Transfusion, Xiangya Hospital, Clinical Transfusion Research Center, Central South University, Changsha 410008, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Zitieren
APA
Jiang, W., Wang, M., Yu, X., Liu, G., He, X., Mei, C., & Ou, C. (2025). Malignant features related PRDX1 associated with osimertinib sensitivity of EGFR-mutant lung adenocarcinoma. International Journal of Medical Sciences, 22(9), 2040-2058. https://doi.org/10.7150/ijms.107255
Vancouver
Jiang W, Wang M, Yu X, Liu G, He X, Mei C, et al. Malignant features related PRDX1 associated with osimertinib sensitivity of EGFR-mutant lung adenocarcinoma. International Journal of Medical Sciences. 2025;22(9):2040-2058. doi:10.7150/ijms.107255
BibTeX
@article{Jiang2025,
author = {Jiang, Wenying and Wang, Maonan and Yu, Xiaoqian and Liu, Guoqian and He, Xiaoyun and Mei, Cheng and Ou, Chunlin},
title = {Malignant features related PRDX1 associated with osimertinib sensitivity of EGFR-mutant lung adenocarcinoma},
journal = {International Journal of Medical Sciences},
year = {2025},
volume = {22},
number = {9},
pages = {2040--2058},
doi = {10.7150/ijms.107255}
}
EUVIMED